Article thumbnail

Signal detection for statin-associated muscular adverse events.

By Toshiyuki Sakaeda (17393), Kaori Kadoyama (337036) and Yasushi Okuno (61219)


<p>N: the number of co-occurrences.</p><p>PRR: the proportional reporting ratio <a href="" target="_blank">[19]</a>, ROR: the reporting odds ratio <a href="" target="_blank">[20]</a>, IC: the information component <a href="" target="_blank">[21]</a>, EBGM: the empirical Bayes geometric mean <a href="" target="_blank">[22]</a>.</p><p>CI: the confidence interval; two-sided for ROR and IC, and one-sided for EBGM.</p><p>*: signal detected, see “<a href="" target="_blank">Methods</a>” for the criteria of detection.</p><p>Myalgia, rhabdomyolysis and increase of creatine phosphokinase (CPK) level were coded as PT10028411, PT10039020 and PT10005470, respectively.</p

Topics: Pharmacology, Biotechnology, Immunology, Mathematics, detection, statin-associated, muscular, adverse
Year: 2013
DOI identifier: 10.1371/journal.pone.0028124.t001
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.